Hepatitis B virus is a DNA virus and Hepatitis C virus has a very high mutation rate with 11 genotypes and many subtypes which can easily escape the immune system recognition. It can cause cirrhosis and liver failure if it lasts for more than three months. Hepatitis C can lead to hepatocellular carcinoma and in some cases death. Treatments for hepatitis-induced liver disease can be surgical such as tumor incision or liver transplant. Nonsurgical treatments include“percutaneous ethanol injection, transarterial embolization, radiofrequency ablation, chemotherapy, and radiotherapy” (John 1). Treatment choices are made based on liver function and cancer prognosis.

Interferons are used to decrease viral replication and thus eliminate or reduce liver complications. Medications such as lamivudine, adefovir, entecavir, and telbivudine target viral replication and have been found to be effective. With transplantation, oral medications prevent Hepatitis B but not Hepatitis C recurrence.